Superworth

Seaport Therapeutics SPTX

Drug Manufacturers - General, Healthcare
$20.01
+2.09%
Market cap
$1.1B
PE
n/m
one or more of the four quarters through 2026-09-30 missing
Forward PE
n/m
not a meaningful number
Price to sales
n/m
not a meaningful number
EV/EBIT
n/m
not a meaningful number
Revenue, 12 months
n/m
not a meaningful number
Net margin
n/m
not a meaningful number
Free cash flow yield
n/m
not a meaningful number

Charts

Financials

Income statement for SPTX, by quarter
Income statementQ1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
R&D$10.5M$13.4M$20.5M$21.4M$24.6M$23.9M
SG&A$5.7M$5.1M$5M$6.1M$41.2M$6.5M
−$16.2M−$18.5M−$25.4M−$27.5M−$65.8M−$30.3M
Pre-tax income−$13.1M−$14.9M−$22.4M−$24.9M−$62.3M−$26.3M
$31K$134K$95K$519K$251K$127K
Net income−$13.1M−$15.1M−$22.5M−$25.4M−$62.6M−$26.4M
−$5.65−$6.40−$9.43−$10.34−$1.78−$0.49
2.3M2.4M2.4M2.5M35.2M53.5M

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Drug Manufacturers - General nearest Seaport Therapeutics' size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
SPTXSeaport Therapeutics$1.1Bn/mn/an/mn/mn/m
AMPHAmphastar Pharmaceuticals$1.1B15.9×20.5×1.6×+1%10.8%
OMEROmeros$1.3B11.7×11.7×n/mn/mn/m
ANABAnaptysbio$1.4B10.3×99.3×n/mn/mn/m
ABUSArbutus Biopharma$791.4M5.1×5.6×4.4×n/m84.2%
PCRXPacira BioSciences$1.5B104×65.7×1.9×+6%2.0%
COLLCollegium Pharmaceutical$770.9M19.1×19.1×1.0×+14%5.9%
PAHCPhibro Animal Health$1.6B15.9×21.5×1.0×+17%6.6%
ANIPANI Pharmaceuticals$1.6B15.0×57.5×1.7×+31%11.1%
ZVRAZevra Therapeutics$599.8M10.9×12.2×4.4×+119%42.8%
IRWDIronwood Pharmaceuticals$571.7M4.5×14.8×1.5×+26%33.4%
Peer median$1.2B13.4×19.8×1.6×+17%10.9%

More on Seaport Therapeutics

Each number over time

Its groups

About

Industry
Drug Manufacturers - General
Sector
Healthcare

Valuation data, not investment advice. Prices as of .